Address
Email address
https://euroapteek.eeE-apteek | Euroapteek.eeEuroapteek e-apteegist saate osta kosmeetikatooteid, toidulisandeid ja käsimüügiravimeid. Lisaks saate e-apteegist oste sooritada igal pool, Teile sobival ajal.
Name
OÜ PharmaFifteen
Registry code
14915654
VAT number
EE102233843
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.02.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
4 711 887 €
1 710 €
0%
2 780 €
(estimate is approximate)
-78 731 €
3
Submitted
No tax arrears
-2%
0%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: KRISTINA KUZINA 16.12.1979 (44) | 51% - 1 275.00 EUR | Board member | Direct ownership | |
| Omanikukonto: DARINA KOVALEVA 22.01.1986 (38) | 49% - 1 225.00 EUR | Board member | Direct ownership | |
| Osaühing EUROAPTEEK 11036389 | - | - | - | Founder |
| 2020 30.06.2021 | 2021 29.06.2022 | 2022 21.06.2023 | 2023 25.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 2 505 523 € | 3 856 088 € | 4 134 318 € | 4 711 887 € |
| Net profit (loss) for the period | -259 115 € | 155 602 € | 20 572 € | 1 710 € |
| Profit Margin | -10% | 4% | 0% | 0% |
| Current Assets | 609 388 € | 634 944 € | 1 017 952 € | 891 520 € |
| Fixed Assets | 1 315 496 € | 1 174 043 € | 1 031 499 € | 781 422 € |
| Total Assets | 1 924 884 € | 1 808 987 € | 2 049 451 € | 1 672 942 € |
| Current Liabilities | 2 181 499 € | 1 910 000 € | 2 129 892 € | 1 751 673 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | -256 615 € | -101 013 € | -80 441 € | -78 731 € |
| Employees | 2 | 2 | 4 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 1 216 124.76 € | - | 9 334.79 € | 8 |
| 2023 Q4 | 1 298 723.1 € | 7 886.61 € | 13 405.16 € | 8 |
| 2023 Q3 | 1 068 515.09 € | 939.14 € | 13 601.02 € | 9 |
| 2023 Q2 | 1 145 250.22 € | 6 329.5 € | 16 352.55 € | 5 |
| 2023 Q1 | 1 176 560.7 € | 7 934.34 € | 15 536.78 € | 5 |
| 2022 Q4 | 1 160 072.09 € | 2 975.63 € | 15 414.03 € | 5 |
| 2022 Q3 | 942 959.55 € | 9 603.8 € | 15 942.4 € | 5 |
| 2022 Q2 | 964 389.4 € | - | 7 280.75 € | 4 |
| 2022 Q1 | 1 011 481.41 € | - | 5 550.24 € | 2 |
| 2021 Q4 | 1 079 386.81 € | 11 491.49 € | 6 352.86 € | 2 |
| 2021 Q3 | 898 733.69 € | - | 6 299.21 € | 2 |
| 2021 Q2 | 934 550.48 € | 8 043.15 € | 5 430.45 € | 2 |
| 2021 Q1 | 877 205.56 € | 5 898.76 € | 6 398.52 € | 2 |
| 2020 Q4 | 854 728.98 € | 4 836.41 € | 5 250.8 € | 2 |
| 2020 Q3 | 796 062.02 € | 6 918.62 € | 7 496.73 € | 3 |
| 2020 Q2 | 494 918.65 € | - | - | 3 |
| 2020 Q1 | - | - | - | - |
